Intent To Grant an Exclusive License of U.S. Government-Owned Patent, 26954 [2014-10757]
Download as PDF
emcdonald on DSK67QTVN1PROD with NOTICES
26954
Federal Register / Vol. 79, No. 91 / Monday, May 12, 2014 / Notices
same electronic docket and downloaded
for review/testing. Follow the
instructions at https://
www.regulations.gov for submitting
comments. Please submit comments on
any given form identified by docket
number, form number, and title.
FOR FURTHER INFORMATION CONTACT: To
request more information on this
proposed information collection or to
obtain a copy of the proposal and
associated collection instruments,
please write to the TACOM LCMC CIO
G6, ATTN: Vaishali, Patel, Bld 230 Rm
100E, 6501 E Eleven Mile Rd, Warren,
MI 48397–5000, or call 585–282–5141
or email vaishali.patel.civ@mail.mil.
SUPPLEMENTARY INFORMATION:
Title; Associated Form; and OMB
Number: EMPLOYEE DEPLOYMENT
TRACKING SYSTEM (EDTS); systemgenerated form, 0702–XXXX.
Needs and Uses: The information
collection requirement is necessary for
deployment processing POCs. The POCs
requires this information to process the
deployment request for a candidate
prior their deployment; this includes
processing their reservation request
prior to travelling to in processing
center. It is also required to process the
candidate’s pay rolls once deployed, if
a candidate deploys based on the in
processing.
Affected Public: Individuals
(Contracting Personnel).
Annual Burden Hours: 5 hr.
Number of Respondents: 100.
Responses per Respondent: 1.
Average Burden per Response: 3
minutes.
Frequency: On occasion.
Respondents are candidates seeking
deployment from TACOM/(and AMC).
The deployment application will
automate the current deployment
process AMC wide and eventually army
wide. It provides an efficient way to
collect, store, and route the deployment
information/forms to respective POC
(supervisor, CRC, ASC, G3 POC) based
on the deployment status. The system
will allow the POC to track the
deployment accurately based on the
date, and given period. The application
will also send notifications to the
candidate, supervisor and G3 POC based
on the Deployment status. The new
application will also control user access
on need to know basis.
Dated: May 6, 2014.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2014–10720 Filed 5–9–14; 8:45 am]
BILLING CODE 5001–06–P
VerDate Mar<15>2010
18:00 May 09, 2014
Jkt 232001
Department of the Army
Intent To Grant an Exclusive License
of U.S. Government-Owned Patent
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
In accordance with 35 U.S.C.
209(e) and 37 CFR 404.7(a)(1)(i),
announcement is made of the intent to
grant an exclusive, royalty-bearing,
revocable license to PCT Application
PCT/2013/040641 filed May 10, 2013,
entitled ‘‘Toxin Detection Using Stem
Cell Derived Neurons’’ to SynActive
Bioscience, LLC, with its principal place
of business at 813 S. Rose Street,
Baltimore, MD 21224.
ADDRESSES: Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, MD 21702–5012.
FOR FURTHER INFORMATION CONTACT: For
licensing issues, Dr. Paul Mele, Office of
Research & Technology Assessment,
(301) 619–6664. For patent issues, Ms.
Elizabeth Arwine, Patent Attorney, (301)
619–7808, both at telefax (301) 619–
5034.
SUMMARY:
Anyone
wishing to object to grant of this license
can file written objections along with
supporting evidence, if any, within 15
days from the date of this publication.
Written objections are to be filed with
the Command Judge Advocate (see
ADDRESSES).
SUPPLEMENTARY INFORMATION:
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014–10754 Filed 5–9–14; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Department of the Army
Intent To Grant an Exclusive License
of U.S. Government-Owned Patent
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
In accordance with 35 U.S.C.
209(e) and 37 CFR 404.7(a)(1)(i),
announcement is made of the intent to
grant an exclusive, royalty-bearing,
revocable license to PCT Application
PCT/2014/22042 filed March 7, 2014,
entitled ‘‘Methods of Detecting
Neurotoxin Using Synaptic Activity’’ to
SynActive Bioscience, LLC, with its
principal place of business at 813 S.
Rose Street, Baltimore, MD 21224.
SUMMARY:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, MD 21702–5012.
FOR FURTHER INFORMATION CONTACT: For
licensing issues, Dr. Paul Mele, Office of
Research & Technology Assessment,
(301) 619–6664. For patent issues, Ms.
Elizabeth Arwine, Patent Attorney, (301)
619–7808, both at telefax (301) 619–
5034.
SUPPLEMENTARY INFORMATION: Anyone
wishing to object to grant of this license
can file written objections along with
supporting evidence, if any, within 15
days from the date of this publication.
Written objections are to be filed with
the Command Judge Advocate (see
ADDRESSES).
ADDRESSES:
DEPARTMENT OF DEFENSE
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014–10757 Filed 5–9–14; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF EDUCATION
[Docket No. ED–2014–ICCD–0064]
Agency Information Collection
Activities; Comment Request;
Independent Living Services for Older
Individuals Who Are Blind
Office of Special Education and
Rehabilitative Service (OSERS),
Department of Education (ED).
ACTION: Notice.
AGENCY:
In accordance with the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 3501 et seq.), ED is
proposing an extension of an existing
information collection.
DATES: Interested persons are invited to
submit comments on or before July 11,
2014.
ADDRESSES: Comments submitted in
response to this notice should be
submitted electronically through the
Federal eRulemaking Portal at https://
www.regulations.gov by selecting
Docket ID number ED–2014–ICCD–0064
or via postal mail, commercial delivery,
or hand delivery. If the regulations.gov
site is not available to the public for any
reason, ED will temporarily accept
comments at ICDocketMgr@ed.gov.
Please note that comments submitted by
fax or email and those submitted after
the comment period will not be
accepted; ED will ONLY accept
comments during the comment period
in this mailbox when the regulations.gov
site is not available. Written requests for
information or comments submitted by
postal mail or delivery should be
SUMMARY:
E:\FR\FM\12MYN1.SGM
12MYN1
Agencies
[Federal Register Volume 79, Number 91 (Monday, May 12, 2014)]
[Notices]
[Page 26954]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10757]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Intent To Grant an Exclusive License of U.S. Government-Owned
Patent
AGENCY: Department of the Army, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i),
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license to PCT Application PCT/2014/22042 filed
March 7, 2014, entitled ``Methods of Detecting Neurotoxin Using
Synaptic Activity'' to SynActive Bioscience, LLC, with its principal
place of business at 813 S. Rose Street, Baltimore, MD 21224.
ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,
MD 21702-5012.
FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele,
Office of Research & Technology Assessment, (301) 619-6664. For patent
issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808, both at
telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this
license can file written objections along with supporting evidence, if
any, within 15 days from the date of this publication. Written
objections are to be filed with the Command Judge Advocate (see
ADDRESSES).
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2014-10757 Filed 5-9-14; 8:45 am]
BILLING CODE 3710-08-P